TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jesper Søndergaard Marino, Ph.D.
Principal Scientist, Biophysics and Injectable Formulation 1 at Novo Nordisk A/S

Profile

Jesper Søndergaard Marino is Principal Research Scientist at department of Biophysics and Injectable Formulation 1 at Novo Nordisk A/S in Maaloev, Denmark. His research interests include Lab Automation, Protein Biophysics and technological innovation. Jesper has a Master’s degree in Molecular Biology and a PhD in Protein Biophysics. He has worked 2½ years as research scientist at ilochip A/S, Denmark and 2½ years as postdoc in the Morimoto Lab at Northwestern University, USA. He joined Novo Nordisk in 2011 as postdoc working on sub-visible protein particle characterization. He is currently spearheading lab-automation efforts within the biophysics and formulation area.

Jesper Søndergaard Marino, Ph.D.'s Network

Agenda Sessions

  • Automated Approaches to Peptide Preformulation and Biophysics

    , 11:05

Speakers at this event